Company intelligence / Profile preview

Penwest Pharmaceuticals Co.

Patterson, New York, United Statespharmaceuticalonline.com ↗

Ownership: Private
Development stage: Commercial

Overview

Penwest developed drug delivery technologies, most notably TIMERx, which was used in Opana ER, a pain management product marketed by Endo Pharmaceuticals

Therapeutic areas: Neurology
Modalities: Small molecules
Industry: Biotech

Drug pipeline

3 assets

oxymorphone

Commercial

Indications: inflammatory / nociceptive pain

2 more assets in the full pipeline.

Request access →

Partnerships

Endo Pharmaceuticals (since 1997)Otsuka Pharmaceutical Co., Ltd.

Beyond the preview

Go deeper on Penwest Pharmaceuticals Co..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Penwest Pharmaceuticals Co..

Explore the full profile